在STXBP1相关疾病中,早期发作和发作
Kim M Thalwitzer1,2,3,4, Julie Xian1,2,3,5, Danielle de Campo1,2,5
1Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Epilepsia
|January 27, 2024
概括
在STXBP1-DEE中,早期发作的发作不会增加患发作的风险. 抗发作药物似乎也没有影响这些人的发育.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 临床神经学 临床神经学
背景情况:
- 与STXBP1相关的发育性和性脑病变 (DEE) 通常伴有早期发作的,包括性.
- 早期发作和抗发作药物 (ASM) 对STXBP1-DEE发作发作的发展和轨迹的影响尚不清楚.
研究的目的:
- 研究STXBP1-DEE患者早期发作和随后发生发作之间的关系.
- 评估抗发作药物 (ASM) 对发生发作的风险的影响.
- 为改善治疗和预后提供基线数据.
主要方法:
- 对61名STXBP1-DEE患者的每周间隔的发作和药物治疗史的回顾性分析,以及在生命的第一年内出现的情况.
- 纵向史和ASM反应的定量分析.
主要成果:
- 在有新生儿或婴儿早期发作史的人群中,患发作的风险没有显著增加 (OR=1,P=1).
- 没有发现任何特定的ASM与患发作的风险增加有关.
- 患有先前的人患有耐药性发作 (76%) 的风险更高,这些发作也在较晚的中位年龄 (20周) 出现,而非耐药性发作 (13周) 的风险更高.
结论:
- 在STXBP1-DEE中早期的发作不会增加患发作的风险.
- 抗发作药物似乎不会影响这种人群中发作的发展.
- 结果为STXBP1-DEE的向干预和预后提供了关键的基线数据.
相关概念视频
01:13Seizures: Classification
362
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
362
01:24Arteries of the Lower Limbs
190
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
190
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
303
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
303
01:14Antiepileptic Drugs: Glutamate Antagonists
359
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
359
01:33Pleiotropy
40.5K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.5K
01:20Inborn Errors of Metabolism
160
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
160